ArticleJournal of thoracic disease2022
Analysis of systemic vascular resistance after cardiac surgery: a retrospective cohort study.
Article in Journal of thoracic disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- Mitral valve systemic vascular resistance index in cardiac surgery should be one more enigma.Journal of thoracic disease · 2023Article
Corrections and comments
- Commented on by
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypotension is a dangerous vital sign frequently encountered during the postoperative management of cardiac surgery. However, factors influencing the systemic vascular resistance index (SVRI), which is strongly related to hypotension, are not well understood. This study evaluated the characteristics of the SVRI according to the type of cardiac surgery. Methods: During this retrospective cohort study, we used the clinical data of patients who underwent cardiac surgery at Asahi General Hospital from April 2014 to August 2020. We analyzed their vital signs during the first 12 hours after surgery and evaluated the differences in vital signs among four types of surgery: mitral valve (MV) surgery; aortic valve (AV) surgery; coronary artery bypass grafting (CABG); and thoracic aorta (TA) surgery. Data were compared among these four groups using one-way analysis of variance every 2 hours postoperatively. Those with significant differences were further compared using the post hoc Tukey-Kramer test. Results: A total of 493 patients participated in this study. Overall, the SVRI decreased within 2 hours after the cardiopulmonary bypass surgery. The SVRI after MV surgery was significantly lower than that after other surgery types. The doses of inotropes used for MV surgery and TA surgery were significantly greater than those used for the other surgery types. Conclusions: The SVRI changes significantly after cardiac surgery and may decrease, especially after MV surgery. For better results, it is necessary to consider the differences in the SVRI that are associated with different types of cardiac surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.